Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focus |
precision oncology
|
| gptkbp:foundedYear |
2019
|
| gptkbp:founder |
gptkb:Hans_Clevers
gptkb:David_Hsu Xiling Shen |
| gptkbp:fundedBy |
gptkb:Alexandria_Venture_Investments
gptkb:GV gptkb:Two_Sigma_Ventures Catalio Capital Management Duke Angel Network PearlX |
| gptkbp:headquartersLocation |
gptkb:Durham,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xilis
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
improving cancer treatment through personalized medicine
|
| gptkbp:technology |
MicroOrganoSphere
|
| gptkbp:website |
https://www.xilis.com/
|
| gptkbp:bfsParent |
gptkb:Neotribe_Ventures
|
| gptkbp:bfsLayer |
7
|